Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Myeloid Leukemia in Remission”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00993694
What this trial is testing

Methemoglobinemia in Young Patients With Hematologic Cancer or Aplastic Anemia Treated With Dapsone

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+6 more
Vanderbilt University 41
Testing effectiveness (Phase 2)WithdrawnNCT01843179
What this trial is testing

Sulindac for Patients With AML

Who this might be right for
Acute Myeloid Leukemia
Massachusetts General Hospital
Testing effectiveness (Phase 2)Ended earlyNCT00907582
What this trial is testing

ASCT for Relapsed APL After Molecular Remission

Who this might be right for
Acute Promyelocytic LeukemiaRelapse
Shanghai Jiao Tong University School of Medicine 5
Not applicableStudy completedNCT00920842
What this trial is testing

Study of Metabolic Syndrome in Adolescent and Young Adult Survivors of Childhood Leukemia Who Have Undergone Stem Cell Transplant

Who this might be right for
Cardiovascular ComplicationsLeukemiaLong-term Effects Secondary to Cancer Therapy in Children+1 more
Fred Hutchinson Cancer Center 244
Testing effectiveness (Phase 2)Study completedNCT00509093
What this trial is testing

Imatinib Mesylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Who Have Received Chemotherapy

Who this might be right for
Leukemia
Case Comprehensive Cancer Center 32
Not applicableLooking for participantsNCT06045819
What this trial is testing

Relation Between Venetoclax Plasma Concentration and Remission in Adults with Acute Myeloid Leukemia (PREDICLAX)

Who this might be right for
Adult Acute Myeloid Leukemia
University Hospital, Caen 100
Testing effectiveness (Phase 2)Study completedNCT00112567
What this trial is testing

Total-Body Irradiation, Thiotepa, and Fludarabine in Treating Young Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer

Who this might be right for
LeukemiaMyelodysplastic Syndromes
Fred Hutchinson Cancer Center 20
Testing effectiveness (Phase 2)Study completedNCT02450877
What this trial is testing

Safety, Efficacy and Pharmacodynamics of Azacitidine in Children and Young Adults With Acute Myeloid Leukemia.

Who this might be right for
Leukemia, Myeloid, Acute
Celgene 7
Large-scale testing (Phase 3)Study completedNCT00782145
What this trial is testing

A Web-Based Stem Cell Transplant Support System or Standard Care in Young Patients Undergoing Stem Cell Transplant and Their Families

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+6 more
Tufts Medical Center 198
Testing effectiveness (Phase 2)Study completedNCT00309907
What this trial is testing

Etanercept in Treating Young Patients With Idiopathic Pneumonia Syndrome After Undergoing a Donor Stem Cell Transplant

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaBlastic Phase Chronic Myelogenous LeukemiaChildhood Acute Lymphoblastic Leukemia in Remission+22 more
Children's Oncology Group 39
Not applicableStudy completedNCT06565975
What this trial is testing

Characteristics and Outcomes of Acute Myeloid Leukemia (AML) Patients Treated With Oral-Azacitidine Maintenance Therapy in France

Who this might be right for
Acute Myeloid Leukemia (AML)
Bristol-Myers Squibb 112
Testing effectiveness (Phase 2)Study completedNCT01350245
What this trial is testing

Bone Marrow Transplantation of Patients in Remission Using Partially Matched Relative Donor

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic SyndromesBiphenotypic Leukemia+7 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 28
Not applicableStudy completedNCT00897767
What this trial is testing

Collecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Treatment Clinical Trial

Who this might be right for
LeukemiaLymphoma
Eastern Cooperative Oncology Group 1,873
Testing effectiveness (Phase 2)Study completedNCT00782379
What this trial is testing

Combination Chemotherapy, Donor Stem Cell Transplant, Tacrolimus, Mycophenolate Mofetil, and Cyclophosphamide in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMyelodysplastic Syndromes
Northside Hospital, Inc. 20
Early research (Phase 1)UnknownNCT00769613
What this trial is testing

Emergency Use of Donor Lymphocytes in Treating Patients Who Have Undergone Donor Stem Cell Transplant and Have Cytomegalovirus Infections

Who this might be right for
Cancer
Milton S. Hershey Medical Center 20
Early research (Phase 1)Study completedNCT00042900
What this trial is testing

Pyroxamide in Treating Patients With Advanced Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+5 more
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Study completedNCT00004056
What this trial is testing

Combination Chemotherapy Followed by Melphalan and Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Acute Myeloid Leukemia

Who this might be right for
Leukemia
Children's Oncology Group 35
Early research (Phase 1)Study completedNCT01690624
What this trial is testing

BI 836858 Dose Escalation in Patients With Refractory or Relapsed Acute Myeloid Leukemia and in Patients With AML in Complete Remission With High Risk to Relapse

Who this might be right for
Leukemia, Myeloid, Acute
Boehringer Ingelheim 30
Testing effectiveness (Phase 2)Study completedNCT04712942
What this trial is testing

Treatment of MDS/AML Patients With an Impending Hematological Relapse With AZA or ATA and Pevonedistat

Who this might be right for
Acute Myeloid Leukemia in RemissionMyelodysplastic SyndromesMinimal Residual Disease
University of Leipzig 14
Early research (Phase 1)Ended earlyNCT01643603
What this trial is testing

Dasatinib for Immune Modulation After Donor Stem Cell Transplant for Hematologic Malignancies

Who this might be right for
Non-Hodgkin's LymphomaHodgkin's LymphomaMyeloid Leukemia+3 more
Barbara Ann Karmanos Cancer Institute 5
Next Page